# P16-L Role Simulation — Brutally Honest

**Date:** 2026-06-01  
**Sprint:** P16-L — Real Market Validation  
**Method:** Persona replay on P16-I/J/K evidence + P16-G revalidations. No new product assumptions.  
**Build state:** Sprint A local product_only 74/100; commercial pack 75/100; zero real trial proof.

---

## Role A — Founder (Andy)

### Context

Andy built the triage engine, ran P16-I UI sprint, closed P16-K commercial pack. Has not logged Preview E2E. Knows every workaround.

### Would continue using it?

**Yes — locally, for demos and supervised trials.**

Andy completes the full loop in 10 steps (P16-J walkthrough). He would screen-share to Chen Kui today from laptop.

### Would abandon it?

**Abandon external URL drop today.** Preview SSO + Production wrong UX = embarrassment. Andy correctly frozen Production.

### Why?

| Factor | Effect |
|--------|--------|
| Engine quality | Sticky — guardrails PASS, drafts copy-ready |
| Distribution gap | Blocks scale — no broker-stable URL |
| Proof gap | Blocks payment ask — zero minutes-saved log |
| Over-help risk | Andy may click for broker during Day 0 and invalidate validation |

**Verdict:** Andy continues as operator. He does **not** yet have evidence the product survives without him in the room.

---

## Role B — Chen Kui (Broker owner)

### Context

California auto broker; WeChat-heavy; pays for minutes on urgent messages. P16-G score 54/100; payment intent 22/100. P16-K fixed pricing/terms — blockers #2–3 from P16-G now closed on paper.

### Would continue using it?

**Maybe — supervised Day 0 only; uncertain Days 1–7.**

P16-G: "MAYBE — supervised only." Cancellation paste API-proven. P16-I fixed wrong tab and Add-Car confusion. He would paste cancellation on a call with Andy.

### Would abandon it?

**Likely abandon if:**
- Sent unsupervised Preview URL (login wall)
- Day 1 draft requires 大改 on every real Chinese thread
- Paste feels slower than reading WeChat directly for routine messages
- No reminder → forgets by Day 3

**Unlikely abandon if:**
- Day 0 real cancellation saves 10+ min with 小改 draft
- Stable URL works all week
- Missing-doc scenario also works by Day 3

### Why?

| Continue driver | Abandon driver |
|-----------------|----------------|
| Same-day urgency on cancellation | Paste fatigue vs native WeChat |
| Collected vs Still needed on missing-doc | English draft on mixed-language paste |
| $49 anchor credible post-P16-K | Zero proof on *his* threads yet |
| Trust: 不自动发送 | Vercel login feels like IT project |

**Payment today:** No (P16-G, P16-K audit).  
**Payment after Day 7 (if gates pass):** Maybe $49 (45% forecast). $99 unlikely without assistant.

**Verdict:** Chen Kui is the **right archetype** but **not yet convinced**. One bad real triage on cancellation kills the trial.

---

## Role C — Office Assistant

### Context

50+ conversations/day; WeChat-primary; follows broker mandate. P16-G assistant score 50/100. P16-I promoted follow-up paste but two mental models remain.

### Would continue using it?

**Uncertain — only if Chen Kui mandates.**

Without mandate: uses for urgent cancellations only, reverts for routine. P16-G: "PARTIALLY revert to WeChat."

### Would abandon it?

**Yes on Day 0** if Vercel login + no training.  
**Yes by Day 7** if broker doesn't mandate and paste adds steps vs typing quick reply in WeChat.

### Why?

| Factor | Score impact |
|--------|--------------|
| Queue + urgency sort | + (saves re-read time) |
| Vercel login | −− (looks like broken IT) |
| Finding follow-up paste | − (was buried; P16-I improved) |
| No mobile proof | − (assistant on phone) |
| No morning ritual | − (needs stable Production URL) |

**Verdict:** Assistant is **$99 tier evidence**, not $49 tier. Do not count assistant adoption in Week 1 unless Chen Kui explicitly assigns cases.

---

## Role D — Skeptical Broker (not Chen Kui; second-broker archetype)

### Context

Cold arrival; no founder; no relationship debt. Represents any broker who didn't build the product.

### Would continue using it?

**No — Day 1.**

10-second test: 72/100 locally but **FAIL on Preview URL** (401 before UI). P16-J: investor/guest persona bounces at login wall.

### Would abandon it?

**Immediately** at SSO or wrong Production tab (客户报送 default, Simulation visible).

### Why?

| Objection | Evidence |
|-----------|----------|
| "Is this finished?" | Dark shell header, Chen Kui branding |
| "Why paste?" | No WeChat sync — must accept manual workflow |
| "Why pay?" | No pricing on screen; no peer testimonial |
| "Who else uses this?" | Zero paying brokers |

**Verdict:** Product is **not ready for cold broker acquisition**. Chen Kui trial is relationship-supervised validation, not market validation at scale.

---

## Role E — Existing Customer (hypothetical: paid $49 for one month)

### Context

Assume Chen Kui paid $49 after successful Day 7. Month 2 behavior simulation.

### Would continue using it?

**Maybe — 60% retention if Month 1 habit formed.**

Continues if: ≥8 cases/month, cancellation + missing-doc still work, URL stable, no major triage regression.

### Would abandon it?

**Churn triggers:**
- Production promote breaks UX (regression to pre–Sprint A)
- Draft quality drops (OpenAI quota → rules fallback unnoticed)
- Paste fatigue — broker stops after week 2 without queue habit
- Assistant never adopted — broker questions $49 vs just using ChatGPT

### Why?

| Retain | Churn |
|--------|-------|
| Case history in queue | "I can do this in ChatGPT free" |
| Insurance-specific structure | No sync still hurts at scale |
| Sunk cost + terms | Better competitor or carrier tool |

**Verdict:** First payment ≠ product-market fit. Month 2 retention requires **habit + stable infra** — neither proven.

---

## Cross-role summary

| Role | Continue? | Abandon? | Blocks $49? | Blocks $99? |
|------|-----------|----------|-------------|-------------|
| A Founder | Yes (local) | URL drop | Over-helping | N/A |
| B Chen Kui | Maybe | Unsupervised URL, bad triage | No trial proof | No assistant proof |
| C Assistant | Uncertain | No mandate, login | N/A | Yes |
| D Skeptical | No | SSO, cold | No testimonial | No office proof |
| E Existing (hypothetical) | Maybe | Paste fatigue, regression | Month 2 churn | Never upgraded |

---

## Brutal honesty statement

The product **works in the room with Andy**. It **has not proven** it works in Chen Kui's office alone. Role simulation does not replace a real trial — it predicts **supervised trial is viable**, **unsupervised trial is not**, and **$49 is plausible but not probable** until log v3 fills with real cases.

---

*End of P16-L Role Simulation*
